Status:
UNKNOWN
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
Lead Sponsor:
Université de Sherbrooke
Conditions:
HPV Infection
Cervical Cancer Screening
Eligibility:
FEMALE
21-65 years
Phase:
NA
Brief Summary
We propose a cross-sectional study to explore the acceptability and feasibility of HPV self-sampling among Quebec women. The study will invite eligible women to self-sample for HPV at home. The HPV ri...
Eligibility Criteria
Inclusion
- Speak and understand French without help
- Have internet access (for completing forms)
- Have a mailing address
Exclusion
- Known positive HPV status • Have already had a hysterectomy
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05414929
Start Date
April 4 2022
End Date
June 30 2022
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, j1n4j6